- Home
- Our company
- Social impact
- Global health equity
- Pioneering the next generation of treatment solutions
Pioneering the next generation of treatment solutions
We support innovation across the continuum of care, to help to develop new technologies, treatments and vaccines.
The new Ebola clinical trial that’s focused on helping halt future outbreaks
A groundbreaking partnership between countries, health organizations and companies worldwide—including Johnson & Johnson—hopes to find the most promising vaccines to help protect people from the virus.
Featured stories
Meet the Johnson & Johnson Scientist Who’s Helping to Fight Tropical Diseases in His Homeland
Two decades after leaving India, Anil Koul has returned to helm its Institute of Microbial Technology. For Dengue Awareness Month, we caught up with him to learn how he’s hoping to combat this tropical scourge and another disease that kills over a million worldwide.
Janssen Wins Prestigious International Prix Galien Award for MDR-TB Treatment
Ground breaking therapy offers hope for people with Multi-Drug Resistant Tuberculosis (MDR-TB)
How Johnson & Johnson is helping save children around the world from intestinal worm infections
For the fifth anniversary of the London Declaration, we’re sharing the steps the company has taken to fulfill its promise to fight neglected tropical diseases—including the development of a chewable form of mebendazole.
More from Johnson & Johnson
Moving toward a more personalized approach to treating depression
The World Health Organization predicts that depression will be the leading cause of disability across the globe by 2030. Learn how Johnson & Johnson is on a mission to change that.
“Our goal is a solution for every bladder cancer patient”
Meet Christopher Cutie, M.D., the Johnson & Johnson scientist who’s helping change the treatment landscape for people with bladder cancer, the tenth most common cancer in the world.
How Johnson & Johnson is helping healthcare providers remotely monitor and support patient health
Expertise, innovation and insight are fueling the development of remote and AI-powered approaches to healthcare—potentially improving treatment decisions and evolving the way clinical trials are designed and managed.